12 Followers on Owler

IM Therapeutics

Read more
Nandan Padukone's photo - CEO of IM Therapeutics

CEO

Nandan Padukone

CEO Approval Rating

90/100

Founded:

2015

Status:

PrivateIndependent Company

IM THERAPEUTICS TOP COMPETITORS OR ALTERNATIVES

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

Missing a competitor? Contribute!

BioIncept is IM Therapeutics's top competitor. BioIncept is headquartered in New York, New York, and was founded in 2001. BioIncept is in the Biotechnology field. BioIncept generates 615% the revenue of IM Therapeutics.

AnTolRx is seen as one of IM Therapeutics's top competitors. AnTolRx's headquarters is in Cambridge, Massachusetts, and was founded in 2014. Like IM Therapeutics, AnTolRx also operates in the Pharmaceuticals field. AnTolRx generates 250% of IM Therapeutics's revenue.

Curavac has been one of IM Therapeutics's top competitors. Curavac was founded in 2002, and its headquarters is in Wilmington, Delaware. Like IM Therapeutics, Curavac also works within the Pharmaceuticals industry. Curavac has 15 fewer employees than IM Therapeutics.

IM Therapeutics Acquisitions

No recent acquisitions found related to IM Therapeutics

IM Therapeutics Funding History

Since IM Therapeutics was founded in 2015, it has participated in 4 rounds of funding. In total IM Therapeutics has raised $13.8M. IM Therapeutics' last funding round was on Oct 2019 for a total of $10.0M

ROUND

FUNDING DATE

AMOUNT

INVESTORS

Series A
Oct 2019
$10M

JDRF T1D Fund

Equity
Jun 2019
$3M
-
Debt
Jul 2016
$350K
-
Equity
Jun 2015
$500K
-

Since IM Therapeutics was founded in 2015, it has participated in 4 rounds of funding. In total IM Therapeutics has raised $13.8M. IM Therapeutics' last funding round was on Oct 2019 for a total of $10.0M

IM Therapeutics Investments

No recent investments found related to IM Therapeutics

IM Therapeutics News

IM Therapeutics Press Releases

Social Media

IM Therapeutics Headquarters

299 Washington Street Suite A

Woburn, Massachusetts01801

1-617-356-8170

Driving Directions »

Trending Companies

IM Therapeutics Summary

ABOUT

Overview

IM Therapeutics is a biotechnology company that develops and commercializes small molecule therapies for the treatment of autoimmune diseases. IM Therapeutics was founded in 2015. IM Therapeutics' headquarters is located in Woburn, Massachusetts, USA ...

CEO

IM Therapeutics's CEO, Nandan Padukone, currently has an approval rating of 90%. IM Therapeutics's primary competitors are BioIncept, AnTolRx & Curavac.

Frequently Asked Questions about IM Therapeutics

  1. When was IM Therapeutics founded?

    IM Therapeutics was founded in 2015
  2. Who is IM Therapeutics's CEO?

    IM Therapeutics's CEO is Nandan Padukone
  3. How much revenue does IM Therapeutics generate?

    IM Therapeutics generates $2M in revenue
  4. How much funding does IM Therapeutics have?

    IM Therapeutics has historically raised $13.8M in funding
  1. Where is IM Therapeutics's headquarters?

    IM Therapeutics's headquarters is in Woburn Massachusetts, USA
  2. How many employees does IM Therapeutics have?

    IM Therapeutics has 30 employees
  3. What sector does IM Therapeutics operate in?

    IM Therapeutics is in Pharmaceuticals
  4. Who are IM Therapeutics's competitors?

    IM Therapeutics's top competitors are BioIncept, AnTolRx, Curavac